MICRO-X LIMITED — Board/Management Information 2025

Jan 14, 2025

PATRICK O’BRIEN TO BE APPOINTED AS CHAIR

Adelaide, Australia, 15 January 2025: Australian hi-tech company Micro-X Ltd (ASX:MX1) ( Micro-X or the Company ), a leader in cold cathode X-ray technology for health and security markets globally, is pleased to announce that Patrick O’Brien will replace David Knox as Chair effective today at which time Mr Knox will retire from the Micro-X Board. Mr O’Brien previously served as Chair from 2015 to 2020 and is currently a nonexecutive director.

Today’s announcement follows Mr Knox’s announcement at the Company’s 2024 AGM of his intention to retire from the Micro-X Board in early 2025. He is retiring to provide the flexibility to spend more time in his native Scotland.

Patrick O’Brien said, “The Board of Micro-X is extremely grateful for the contribution David has made as Chair this last 4 years. Most significantly, he has overseen a critical evolution in the company’s management team to engender a sharpened commercial focus.”

in tangible outcomes and the creation of shareholder value. However, Board renewal is also a continuing priority, with a particular focus on recruiting a long-term Chair with the skills, experience and energy required to deliver on Micro-X’s significant potential.”

This ASX announcement is authorised by the Board of Micro-X.

– ENDS –

About Micro-X

Micro-X Limited (the Company) is an ASX listed hi-tech company developing and commercialising a range of innovative products for global health and security markets, based on proprietary cold cathode, carbon nanotube (CNT) emitter technology. The electronic control emitters with this technology enables x-ray products with significant reduction in size, weight, and power requirements, enabling greater mobility and ease of use in existing x-ray markets and a range of new and unique security and defence applications. Micro-X has a fully vertically integrated design and production facility in Adelaide, Australia. A growing technical and commercial team based in Seattle is rapidly expanding Micro-X’s US business.

Micro-X’s product portfolio spans four, high margin, product applications in health and security. The first mobile digital radiology products are currently sold for diagnostic imaging in global healthcare, military and veterinary applications and the Argus X-ray Camera for security and defence is now commercially available. The US Department of Homeland Security has contracted Micro-X to design a next-generation Airport security checkpoint. A miniature brain CT imager for pre-hospital stroke diagnosis in ambulances, is being developed with funding from the Australian Government’s Medical Research Future Fund.

For more information visit: www.micro-x.com

Contacts

Contacts
Micro-X Limited	Investor Enquiries
Kingsley Hall, Chief Executive OfcerRebecca Puddy, Head of Corporate CommunicationsTel: +61 8 7099 3966Email: media@micro-x.com	David Allen/John GrangerHawesbury PartnersTel: +61 2 9103 9494Email: dallen@hawkesburypartners.comjgranger@hawkesburypartners.com

Micro-X Ltd. ABN 21 153 273 735, 1284 South Road, MAB Gate 2, Tonsley, South Australia 5042 ww.micro-x.com